$30.31−0.15 (−0.49%)
At close: Oct 2, 2026, 4:00 PM ET
Schrodinger Inc · Financials
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Business engineGrowing fast: revenue compounds ~16.7%/yr (FY21→FY25), net margin −40.4%.
The four lines that matter · FY21–FY25
Revenue ($M)▲23.3%
255.9
FY21→FY25CAGR +16.7%/yr
Net income ($M)▲44.8%
−103.3
FY21→FY25CAGR —
Free cash flow ($M)—
12.5
FY21→FY25CAGR —
Diluted EPS▲45.1%
−1.41
FY21→FY25CAGR —
What the receipts whisper · what a headline number hides
Share count
+3.4%
71.0mn → 73.4mn diluted shares since FY21. Broadly flat, so EPS moves with net income rather than with the share count.
Capex
$1.4M
−80.3% YoY in FY25 · 0.6% of revenue.
What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)
-40¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.
Margin trend · direction beats level Gross Operating Net
Over this window: gross 47.6% → 55.7%. Net margin -40.4% is below the sector median.
The receipt · income statement · FY21–FY25 USD thousands except per-share & ratios · hover a line for its definition
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 259,035.0 | 255,869.0 | 207,539.0 | 216,666.0 | 180,955.0 | 137,931.0 | ▲23.3% | +16.7% |
Cost of revenue | 111,724.0 | 113,255.0 | 75,456.0 | 75,974.0 | 79,933.0 | 72,311.0 | ▲50.1% | +11.9% |
Gross profit | 147,311.0 | 142,614.0 | 132,083.0 | 140,692.0 | 101,022.0 | 65,620.0 | ▲8.0% | +21.4% |
Research & development | 168,978.0 | 173,138.0 | 201,785.0 | 181,766.0 | 126,372.0 | 90,904.0 | ▼14.2% | +17.5% |
Selling, general & admin | 90,047.0 | 95,409.0 | 99,677.0 | 99,148.0 | 90,825.0 | 64,009.0 | ▼4.3% | +10.5% |
Total operating expenses | 300,756.0 | 309,510.0 | 341,379.0 | 318,140.0 | 247,839.0 | 177,063.0 | ▼9.3% | +15.0% |
Operating incomefeeds ROC rank | −153,445.0 | −166,896.0 | −209,296.0 | −177,448.0 | −146,817.0 | −111,443.0 | ▲20.3% | — |
Other income, net | 101,514.0 | 64,570.0 | 23,585.0 | 220,367.0 | −2,306.0 | 10,635.0 | — | — |
Pretax income | −51,931.0 | −102,326.0 | −185,711.0 | 42,919.0 | −149,123.0 | −100,808.0 | ▲44.9% | — |
Income tax | 2,404.0 | 939.0 | 1,412.0 | 2,199.0 | 63.0 | 411.0 | ▼33.5% | +22.9% |
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings | −54,335.0 | −103,265.0 | −187,123.0 | 40,720.0 | −149,186.0 | −101,219.0 | ▲44.8% | — |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | −0.73 | −1.41 | −2.57 | 0.54 | −2.10 | −1.42 | ▲45.1% | — |
Diluted shares (mn) | 75.77 | 73.44 | 72.67 | 74.99 | 71.17 | 71.04 | ▲1.1% | +0.8% |
| Margins | ||||||||
Gross margin35th pct in Healthcare | 56.9% | 55.7% | 63.6% | 64.9% | 55.8% | 47.6% | ▼7.9pp | +8.2pp |
Operating margin | −59.2% | −65.2% | −100.8% | −81.9% | −81.1% | −80.8% | ▲35.6pp | +15.6pp |
Net margin27th pct in Healthcare | −21.0% | −40.4% | −90.2% | 18.8% | −82.4% | −73.4% | ▲49.8pp | +33.0pp |
† TTM = trailing four quarters through 2026-06-30.
4 more years of statements and CSV export are on Premium.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2026-02-25 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.